Definitive Contract 75F40119C10116
Award Date
9/30/19
Potential Completion Date
5/31/24
Potential Value
$2.8M
Federal Agency
Food and Drug Administration
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Rosslyn, VA 22209, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
34
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration awarded a $7.4 million firm fixed price delivery order contract to the Medical Device Innovation Consortium, doing business as Mdic, with a period of performance from September 22, 2022 through September 22, 2024. The contract is to strengthen device quality and patient safety initiatives through continued support of Center for Devices and Radiological Health Quality Projects. Mdic will provide services and products to...
The Department of Health and Human Services Food and Drug Administration awarded a $680,071 firm fixed price delivery order contract to the Medical Device Innovation Consortium, doing business as MDIC, to provide training materials for education around device innovation, particularly for training device sponsor applicants. The training materials are required for sponsors entering the device innovation space and will be delivered from MDIC's offices in Silver Spring, Maryland over a one year...
This federal contract award, valued at $811,126.00, was issued by the U.S. Food and Drug Administration (FDA) to Digital Medicine Society Inc., a non-profit organization based in Boston, Massachusetts. The contract was awarded under a Broad Agency Announcement (BAA) solicitation for research and development to support the FDA's regulatory science and innovation mission. The contract is a Definitive Contract with a Firm Fixed Price pricing type, and has an ultimate completion date of December 31,...
This is a cost-plus-fixed-fee delivery order contract awarded by the Food and Drug Administration (FDA) to The Mitre Corporation, a non-profit research organization, valued at $9,824,137.00. The contract is for the FDA Center for Devices and Radiological Health's (CDRH) Resilient Supply Chain and Shortages Prevention Program, which does not have a set-aside designation. Mitre will provide services such as systems engineering, data analytics, and organizational development to support the CDRH's...
The U.S. Food and Drug Administration (FDA) awarded a $4,400,000.00 Cost Plus Fixed Fee contract to Continuus Pharmaceuticals, Inc. to support the "ADVANCEMENT OF INTEGRATED CONTINUOUS MANUFACTURING (ICM) UNIT OPERATIONS." This definitive contract does not have a set-aside designation and is scheduled to be completed by September 29, 2019. The contract is part of the FDA's efforts to advance integrated continuous manufacturing unit operations, which is a major program focus area for...
<p>The U.S. Food and Drug Administration (FDA) has awarded a $332,866 Firm Fixed Price contract to The Milken Institute, a non-profit organization, to perform work under Broad Agency Announcement (BAA) BAA-FY24C1IP3, titled "DEFINING THE VALUE AND RETURN ON INVESTMENT OF PATIENT ENGAGEMENT IN MEDTECH PRODUCT DEVELOPMENT". The contract has a period of performance through March 31, 2026. The award does not include a set-aside designation.</p>
The Department of Health and Human Services Food and Drug Administration awarded a $393,387 definitive contract to Pacific Force Consulting Group LLC. The contract calls for the contractor to conduct quality management maturity assessments at up to nine domestic FDA facilities using their established assessment tool. Additionally, the contractor must train FDA staff to independently conduct similar evaluations. This opportunity was set aside for total small businesses and addresses the...
This is a delivery order contract awarded by the Food and Drug Administration (FDA) to The Mitre Corporation, a not-for-profit organization that operates federally funded research and development centers (FFRDCs). The $4,427,933.97 cost-plus-fixed-fee contract supports the Center for Devices and Radiological Health (CDRH) Case for Quality strategic initiatives under the Centers for Medicare & Medicaid Services (CMS) Alliance to Modernize Healthcare (CAMH) FFRDC. The contract does not have...
This $1,882,168.19 cost-plus-fixed-fee contract was awarded by the Food and Drug Administration (FDA) to The Mitre Corporation, a non-profit organization that operates federally funded research and development centers. The contract, which does not have a set-aside designation, is for strategic engineering and technical support for the FDA's Center for Devices and Radiological Health (CDRH) eSubmissions system. As part of this contract, Mitre is collaborating with a subcontractor, Progress...
The Department of Health and Human Services Food and Drug Administration awarded a $499,998.00 cost-plus-fixed-fee delivery order contract to The Mitre Corporation, a not-for-profit organization, for the "OFFICE OF HEALTH INFORMATIC DATA STANDARDIZATION AND INFORMATION" effort. The contract does not have a set-aside designation and was completed on September 29, 2020. Mitre, which operates federally funded research and development centers to provide technical expertise to the...